Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up

A long-term follow-up (LTFU) of the nine-valent human papillomavirus (9vHPV) vaccine efficacy study in young women aged 16–26 years was initiated to evaluate if vaccine effectiveness for up to 14 years post-vaccination will remain above 90%. Vaccine effectiveness is measured as percent reduction in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Susanne K. Kjaer, Mari Nygård, Karin Sundström, Christian Munk, Sophie Berger, Mensur Dzabic, Katrin Elisabeth Fridrich, Marianne Waldstrøm, Sveinung Wergeland Sørbye, Oliver Bautista, Thomas Group, Alain Luxembourg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2021-04-01
coleção:	Human Vaccines & Immunotherapeutics
Assuntos:	cervical intraepithelial neoplasia effectiveness human papillomavirus long-term follow-up vaccine nine-valent human papillomavirus vaccine
Acesso em linha:	http://dx.doi.org/10.1080/21645515.2020.1839292
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!